ISPOR Good Practice Task Force Recommendations on Valuing HRQoL of Children & Adolescents in Economic Evaluation (Pediatric Utilities)

Author(s)

Moderator: Nancy Joy Devlin, PhD, School of Population and Global Health, University of Melbourne, Melbourne, Australia
Speakers: Louis Matza, PhD, Patient-Centered Research, Evidera, Bethesda, MD, USA; Ernest H Law, PharmD, PhD, Global HEOR, Pfizer, New York, NY, USA; Fleur Chandler, MSc, Sanofi and Patient Advisory Board Lead, Duchenne UK, Reading, Berkshire, Great Britain

ISPOR launched a Good Practice Task Force on pediatric utilities to address the gaps in both methods research and guidance from decision makers about pediatric HRQoL utilities for use in economic evaluation. There is a lack guidance specific to child HRQoL utilities, or the implicit assumption that what is recommended for the valuation of adult HRQoL is also appropriate for children and adolescents. Yet there are a number of methods issues specific to the valuation of HRQoL in children that do not arise in the valuation of adult HRQoL. Moreover, the methods used to preference-weight pediatric HRQoL instruments differ in important ways that decision makers may not be aware of.

This forum will highlight the principal methods issues concerning:

  1. Whose stated preferences are relevant to the preference weighting of pediatric HRQoL states?
  2. What perspective respondents should be asked to adopt in imagining and valuing pediatric HRQoL?
  3. What preference elicitation methods should be used? and
  4. To what extent is the comparability and consistency of health state utilities for adult and child HRQoL important for their use in QALY estimation, economic evaluation and decision making?

The task force will present their recommendations and seek audience feedback on the overall approach taken. Pediatric utilities inevitably involves both HEOR science and normative considerations. Given the pivotal role of value judgements in methods choices in pediatric utilities, consultation with local HTA bodies is essential both to ensure that utilities are ‘fit for purpose’, and to ensure that decision makers are well informed about the role and implications of value judgements when establishing methods guidelines. The session will conclude with a question and answer session.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Code

218

Topic

Patient-Centered Research

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×